Promising CART T cancer therapy invented at Penn linked to rare, secondary cancers, FDA says The Citizen 2 years ago The FDA says it has received 19 reports of new blood cancers in patients who got the CAR T treatment. Source: ABC News 6 Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on Reddit (Opens in new window) Reddit Click to share on LinkedIn (Opens in new window) LinkedIn Click to print (Opens in new window) Print Drugmakers recall blood pressure medicine tainted with cancer-causing chemical, FDA saysDateNovember 1, 2025In relation toRobesoniaZantac carcinogen: FDA says drug still safe to take amidst probeDateSeptember 14, 2019In relation toRobesoniaFDA says it's working as fast as possible to fully approve COVID vaccinesDateJuly 31, 2021In relation toRobesonia
